table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 mild to moderate
COVID-19 mild to moderate
neutralizing antibody
casirivimab/imdevimab (Ronapreve) Somersan-Karakaya ... Suzuki

0 studies excluded by filtering options 2

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons